Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22). | Br J Cancer | 2022 | 35869143 | PubTator, text mining | PubMed |
| Chromatin Ubiquitination Guides DNA Double Strand Break Signaling and Repair. | Front Cell Dev Biol | 2022 | 35865631 | PubTator, text mining | PubMed |
| Next-generation sequencing reveals novel variants and large deletion in FANCA gene in Polish family with Fanconi anemia. | Orphanet J Rare Dis | 2022 | 35854323 | PubTator, text mining | PubMed |
| Analysis of mutations in DNA damage repair pathway gene in Chinese patients with hepatocellular carcinoma. | Sci Rep | 2022 | 35853969 | PubTator, text mining | PubMed |
| Exploring immunotherapy in colorectal cancer. | J Hematol Oncol | 2022 | 35842707 | PubTator, text mining | PubMed |
| DNA repair as a shared hallmark in cancer and ageing. | Mol Oncol | 2022 | 35834102 | PubTator, text mining | PubMed |
| Beth Levine's Legacy: From the Discovery of BECN1 to Therapies. A Mentees' Perspective. | Front Cell Dev Biol | 2022 | 35832792 | PubTator, text mining | PubMed |
| Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies. | JCO Precis Oncol | 2022 | 35820087 | PubTator, text mining | PubMed |
| Atherogenic index of plasma is an independent predictor of metabolic-associated fatty liver disease in patients with type 2 diabetes. | Eur J Med Res | 2022 | 35818084 | PubTator, text mining | PubMed |
| Case Report: Successful Immunotherapy Improved the Prognosis of the Unfavorable Subset of Cancer of Unknown Primary. | Front Immunol | 2022 | 35812375 | PubTator, text mining | PubMed |
| Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial. | Lancet Oncol | 2022 | 35810751 | PubTator, text mining | PubMed |
| Functions of Breast Cancer Predisposition Genes: Implications for Clinical Management. | Int J Mol Sci | 2022 | 35806485 | PubTator, text mining | PubMed |
| Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes. | Int J Environ Res Public Health | 2022 | 35805770 | PubTator, text mining | PubMed |
| The Role of microRNAs in Multidrug Resistance of Glioblastoma. | Cancers (Basel) | 2022 | 35804989 | PubTator, text mining | PubMed |
| Multicellular biomarkers of drug resistance as promising targets for glioma precision medicine and predictors of patient survival. | Cancer Drug Resist | 2022 | 35800363 | PubTator, text mining | PubMed |
| Emerging Therapies in Penile Cancer. | Front Oncol | 2022 | 35800050 | PubTator, text mining | PubMed |
| Association of Vitamin D Anabolism-Related Gene Polymorphisms and Susceptibility to Uterine Leiomyomas. | Front Genet | 2022 | 35795205 | PubTator, text mining | PubMed |
| Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors. | Front Oncol | 2022 | 35785170 | PubTator, text mining | PubMed |
| An Analysis of Algebraic Codes over Lattice Valued Intuitionistic Fuzzy Type-3 R-Submodules. | Comput Intell Neurosci | 2022 | 35785082 | PubTator, text mining | PubMed |
| Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D. | Breast | 2022 | 35772246 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=43